Literature DB >> 11050260

Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: evaluation of nasal response by acoustic rhinometry.

J Casadevall1, P J Ventura, J Mullol, C Picado.   

Abstract

BACKGROUND: Nasal provocation tests with lysine-aspirin have recently been introduced for assessment of aspirin intolerant asthma. A study was undertaken to evaluate the usefulness of acoustic rhinometry, a new non-invasive technique, in the diagnosis of aspirin intolerant asthma/rhinitis.
METHODS: Fifteen patients with aspirin intolerant asthma/rhinitis (nine women, mean (SD) age 54.7 (14) years), eight patients with aspirin tolerant asthma/rhinitis (three women, mean (SD) age 52.6 (7.8) years), and eight healthy subjects (two women, mean (SD) age 32.5 (9.7) years) were studied. All subjects were challenged with saline (0.9% NaCl) and 25 mg lysine acetylsalicylic acid (L-ASA) instilled into each nostril of the nose on two separate days. The clinical response was evaluated based on nasal symptoms (sneezes, itching, secretion and blockage). The nasal response was measured by acoustic rhinometry. Symptoms and rhinometry curves were recorded at 10 minute intervals for three hours, one hour before challenge and two hours after challenge.
RESULTS: L-ASA challenge induced a significant increase in symptoms in patients with aspirin intolerant asthma/rhinitis. No differences in the clinical response were detected in those with aspirin tolerant asthma/rhinitis or healthy subjects. L-ASA challenge induced a significant decrease in nasal volume measured by acoustic rhinometry in aspirin intolerant patients. No differences were detected between the challenges in aspirin tolerant patients. If a 25% decrease in nasal volume is taken as the cut off point, the specificity of the test was 94% and the sensitivity reached 73%. The nasal challenge was well tolerated by all subjects.
CONCLUSION: Acoustic rhinometry may be used to study the nasal response to L-ASA. Nasal challenge with L-ASA is safe and can be used as a diagnostic test even in asthmatic patients with severe bronchial obstruction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11050260      PMCID: PMC1745635          DOI: 10.1136/thorax.55.11.921

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  17 in total

1.  Acoustic rhinometry: evaluation of the nasal cavity with septal deviations, before and after septoplasty.

Authors:  L F Grymer; O Hilberg; O Elbrønd; O F Pedersen
Journal:  Laryngoscope       Date:  1989-11       Impact factor: 3.325

2.  Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma.

Authors:  A S Cowburn; K Sladek; J Soja; L Adamek; E Nizankowska; A Szczeklik; B K Lam; J F Penrose; F K Austen; S T Holgate; A P Sampson
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

3.  Acoustic rhinometry: evaluation of nasal cavity geometry by acoustic reflection.

Authors:  O Hilberg; A C Jackson; D L Swift; O F Pedersen
Journal:  J Appl Physiol (1985)       Date:  1989-01

4.  Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma.

Authors:  M Milewski; L Mastalerz; E Nizankowska; A Szczeklik
Journal:  J Allergy Clin Immunol       Date:  1998-05       Impact factor: 10.793

5.  Inflammatory cell populations and cytokine mRNA expression in the nasal mucosa in aspirin-sensitive rhinitis.

Authors:  E M Varga; M R Jacobson; K Masuyama; S Rak; S J Till; Y Darby; Q Hamid; V Lund; G K Scadding; S R Durham
Journal:  Eur Respir J       Date:  1999-09       Impact factor: 16.671

6.  Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects.

Authors:  S M Nasser; R Pfister; P E Christie; A R Sousa; J Barker; M Schmitz-Schumann; T H Lee
Journal:  Am J Respir Crit Care Med       Date:  1996-01       Impact factor: 21.405

Review 7.  Aspirin-induced asthma: advances in pathogenesis and management.

Authors:  A Szczeklik; D D Stevenson
Journal:  J Allergy Clin Immunol       Date:  1999-07       Impact factor: 10.793

8.  Prevalence of aspirin intolerance in asthmatics treated in a hospital.

Authors:  J A Castillo; C Picado
Journal:  Respiration       Date:  1986       Impact factor: 3.580

9.  Diagnostic value of acoustic rhinometry: patients with allergic and vasomotor rhinitis compared with normal controls.

Authors:  H Lenders; W Pirsig
Journal:  Rhinology       Date:  1990-03       Impact factor: 3.681

10.  Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge.

Authors:  K Sladek; R Dworski; J Soja; J R Sheller; E Nizankowska; J A Oates; A Szczeklik
Journal:  Am J Respir Crit Care Med       Date:  1994-04       Impact factor: 21.405

View more
  10 in total

Review 1.  Aspirin intolerance and nasal polyposis.

Authors:  César Picado
Journal:  Curr Allergy Asthma Rep       Date:  2002-11       Impact factor: 4.806

2.  Distinct transcriptome profiles differentiate nonsteroidal anti-inflammatory drug-dependent from nonsteroidal anti-inflammatory drug-independent food-induced anaphylaxis.

Authors:  Rosa Muñoz-Cano; Mariona Pascal; Joan Bartra; Cesar Picado; Antonio Valero; Do-Kyun Kim; Stephen Brooks; Michael Ombrello; Dean D Metcalfe; Juan Rivera; Ana Olivera
Journal:  J Allergy Clin Immunol       Date:  2015-07-17       Impact factor: 10.793

Review 3.  Rhinosinusitis: Establishing definitions for clinical research and patient care.

Authors:  Eli O Meltzer; Daniel L Hamilos; James A Hadley; Donald C Lanza; Bradley F Marple; Richard A Nicklas; Claus Bachert; James Baraniuk; Fuad M Baroody; Michael S Benninger; Itzhak Brook; Badrul A Chowdhury; Howard M Druce; Stephen Durham; Berrylin Ferguson; Jack M Gwaltney; Michael Kaliner; David W Kennedy; Valerie Lund; Robert Naclerio; Ruby Pawankar; Jay F Piccirillo; Patricia Rohane; Ronald Simon; Raymond G Slavin; Alkis Togias; Ellen R Wald; S James Zinreich
Journal:  Otolaryngol Head Neck Surg       Date:  2004-12       Impact factor: 3.497

Review 4.  Aspirin-induced asthma: clinical aspects, pathogenesis and management.

Authors:  Ahmed M Hamad; Amy M Sutcliffe; Alan J Knox
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 5.  Rhinosinusitis: establishing definitions for clinical research and patient care.

Authors:  Eli O Meltzer; Daniel L Hamilos; James A Hadley; Donald C Lanza; Bradley F Marple; Richard A Nicklas; Claus Bachert; James Baraniuk; Fuad M Baroody; Michael S Benninger; Itzhak Brook; Badrul A Chowdhury; Howard M Druce; Stephen Durham; Berrylin Ferguson; Jack M Gwaltney; Michael Kaliner; David W Kennedy; Valerie Lund; Robert Naclerio; Ruby Pawankar; Jay F Piccirillo; Patricia Rohane; Ronald Simon; Raymond G Slavin; Alkis Togias; Ellen R Wald; S James Zinreich
Journal:  J Allergy Clin Immunol       Date:  2004-12       Impact factor: 10.793

6.  Aspirin-exacerbated respiratory disease: evaluation and management.

Authors:  Rachel U Lee; Donald D Stevenson
Journal:  Allergy Asthma Immunol Res       Date:  2010-08-20       Impact factor: 5.764

7.  Galectin-10 is released in the nasal lavage fluid of patients with aspirin-sensitive respiratory disease.

Authors:  Ma Cristina Negrete-Garcia; Carla Yoneli Jiménez-Torres; Noe Alvarado-Vásquez; A Rosalía Montes-Vizuet; J R Velázquez-Rodriguez; M Carmen Jimenez-Martinez; Luis Manuel Teran-Juárez
Journal:  ScientificWorldJournal       Date:  2012-04-30

Review 8.  Hypersensitivity to Aspirin and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis.

Authors:  Joanna Makowska; Anna Lewandowska-Polak; Marek L Kowalski
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

9.  Signal transduction pathways (MAPKs, NF-κB, and C/EBP) regulating COX-2 expression in nasal fibroblasts from asthma patients with aspirin intolerance.

Authors:  Francesc Josep Garcia-Garcia; Joaquim Mullol; Maria Perez-Gonzalez; Laura Pujols; Isam Alobid; Jordi Roca-Ferrer; Cesar Picado
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

10.  The diamine oxidase gene is associated with hypersensitivity response to non-steroidal anti-inflammatory drugs.

Authors:  José A G Agúndez; Pedro Ayuso; José A Cornejo-García; Miguel Blanca; María J Torres; Inmaculada Doña; María Salas; Natalia Blanca-López; Gabriela Canto; Carmen Rondon; Paloma Campo; José J Laguna; Javier Fernández; Carmen Martínez; Elena García-Martín
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.